Antibody-conjugating nanogel (Conjugel) with two immune checkpoint inhibitors for enhanced cancer immunotherapy
Y. J. Chae, K.-G. Lee, D. Oh, S.-K. Lee, Y. Park, J. Kim
This study develops a nanogel-based system that delivers two immune checkpoint inhibitors, enhancing cancer immunotherapy efficacy and reducing toxicity compared to traditional methods.
bioRxiv · Oct 19, 2023 · PreprintBioengineering